Vectors

Oxford Biomedica and Imperial College announce breakthrough in gene therapy

Published in Gene Therapy Weekly, July 4th, 2002

Oxford BioMedica plc (OXB) and researchers at Imperial College of Science and Technology, London (Imperial College) have achieved very efficient gene transfer to mouse embryos in utero.

The technology, if reproducible in man, creates the potential to cure diseases such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF), diseases that are incurable at present. These developments were presented at the American Society for Gene Therapy (ASGT) meeting in Boston, Massachusetts June 8th, 2002, by Dr. Mike Themis of the Gene Therapy Group, Division of Biomedical Sciences at Imperial College, London.

Diseases that are caused by defects in single...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-07-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry